Drug & intervention

melatonin

RxCUI 6711

Clinical trials47
Recruiting3
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Melatonin

Melatonin, an indoleamine, is a natural compound produced by various organisms, including bacteria and eukaryotes. Its discovery in 1958 by Aaron B. Lerner and colleagues stemmed from the isolation of a substance from the pineal gland of cows that could induce skin lightening in common frogs. This compound was later identified as a hormone secreted in the brain during the night, playing a crucial role in regulating the sleep-wake cycle, also known as the circadian rhythm, in vertebrates. In vertebrates, melatonin's functions extend to synchronizing sleep-wake cycles, encompassing sleep-wake timing and blood pressure regulation, as well as controlling seasonal rhythmicity (circannual cycle), which includes reproduction, fattening, molting, and hibernation. Its effects are mediated through the activation of melatonin receptors and its role as an antioxidant. In plants and bacteria, it serves as a defense mechanism against oxidative stress, indicating its evolutionary significance. Mitochondria, key organelles, are the main producers of melatonin, underscoring its "ancient origins" and its fundamental role in protecting the earliest cells from reactive oxygen species. In addition to its endogenous functions as a hormone and antioxidant, melatonin is also administered exogenously as a dietary supplement and medication. Melatonin is used medically primarily for sleep-related problems: for example, prolonged-release melatonin (Circadin) is approved in several countries for short-term treatment of insomnia in people aged 55 years of age or older. It is used in the treatment of...

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Effect of Melatonin in Patients With Diabetic Peripheral NeuropathyNCT07036796 · 2025-07-04
RECRUITING
Effect of Melatonin on Pulmonary Hypertension in Full Term NeonatesNCT07850934 · 2025-07-01
RECRUITING
Sleep, Diabetic Retinopathy and MelatoninNCT04547439 · 2021-02-03
RECRUITING
Melatonin for Glycemic Control in Gestational Diabetes MellitusNCT07369284 · 2026-02-01
NOT_YET_RECRUITING
Melatonin in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyNCT07067307 · 2025-07-01
NOT_YET_RECRUITING
Efficacy of Melatonin in the Treatment of Diabetic Nephropathy Compared With Folic AcidNCT07825961 · 2025-04-01
COMPLETED
Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive PatientsNCT06935292 · 2025-04-01
NOT_YET_RECRUITING
Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease SpectrumNCT06756828 · 2025-01-15
NOT_YET_RECRUITING
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled TrialNCT06838104 · 2024-12-05
ACTIVE_NOT_RECRUITING
Melatonin for Pulmonary Hypertension in Full Term NeonatesNCT06685679 · 2024-05-15
COMPLETED
Melatonin in Obese Patients in Laparoscopic CholecystectomyNCT06355687 · 2024-04-01
UNKNOWN
Melatonin Effects on the Left Ventricular Function in Neonates With Persistent Pulmonary HypertensionNCT07090720 · 2023-01-01
COMPLETED
Melatonin on Clock Genes in Parkinson's DiseaseNCT04287543 · 2021-05-01
WITHDRAWN
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary SclerosisNCT03540485 · 2019-11-29
TERMINATED
Metabolic Effects of Melatonin TreatmentNCT03859934 · 2019-09-26
COMPLETED
Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With PrediabetesNCT03848533 · 2019-08-22
UNKNOWN
Melatonin's Effects on Treatment Of Diabetes MellitusNCT02691897 · 2019-07-01
UNKNOWN
Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast CancerNCT03716583 · 2019-04-30
COMPLETED
Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic HypotensionNCT02963181 · 2018-03-01
TERMINATED
Study MIPAE - Melatonin and Essential Arterial HypertensionNCT05257291 · 2018-02-02
UNKNOWN
Effect of Melatonin on Cardiometabolic Risk- FULLNCT02681887 · 2016-09-01
UNKNOWN
Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast CancerNCT02486796 · 2016-02-19
TERMINATED
The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1NCT02644590 · 2016-02-01
UNKNOWN
Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.NCT02631148 · 2016-01-01
TERMINATED
Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast CancerNCT02506790 · 2015-07-01
UNKNOWN
Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.NCT02506777 · 2015-07-01
UNKNOWN
Melatonin for Nocturia in Parkinson's DiseaseNCT02359448 · 2015-04-01
UNKNOWN
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving RadiotherapyNCT02332928 · 2015-03-25
TERMINATED
Pharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01
TERMINATED
Anti-proliferative Effects of Vitamin D and Melatonin in Breast CancerNCT01965522 · 2013-10-01
COMPLETED
Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B GeneNCT01705639 · 2012-11-01
COMPLETED
The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy SubjectsNCT02463318 · 2012-09-01
COMPLETED
Melatonin for Prevention of Metabolic Side Effects of OlanzapineNCT01593774 · 2012-05-01
COMPLETED
Effect of Melatonin on Multiple Sclerosis Related FatigueNCT01718678 · 2012-05-01
COMPLETED
Melatonin as Adjuvant Therapy in Breast Cancer PatientsNCT01557478 · 2012-03-01
UNKNOWN
Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With SchizophreniaNCT01431092 · 2011-10-01
COMPLETED
Melatonin in Relapsing-Remitting Multiple Sclerosis PatientsNCT01279876 · 2010-10-01
COMPLETED
Melatonin and Nighttime Blood Pressure in African Americans--24 mg StudyNCT01114373 · 2010-06-01
COMPLETED
Melatonin and Nighttime Blood Pressure in African Americans-8 mg StudyNCT01114360 · 2010-03-01
COMPLETED
Melatonin Supplementation to Improve Sleep in Patients With Heart FailureNCT00869869 · 2009-03-01
WITHDRAWN

Leading sponsors

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.